Atlas Trials

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

Clinical trial NCT04154670 · COMPLETED

Trial details

NCT number
NCT04154670
Sponsor
Ensoma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyRenal Insufficiency
Start date
2019-11-07
Primary completion
2020-03-24
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.